Circulating Tumour DNA for Monitoring Treatment Response to Anti-PD-1 Immunotherapy in Melanoma Patients

by Atsuko Ashida, Kaori Sakaizawa, Hisashi Uhara, Ryuhei Okuyama
Published 2017-08-01

BRAF Mutation Heterogeneity in Melanoma Lesions

by Kaori Sakaizawa, Atsuko Ashida, Yukiko Kiniwa, Ryuhei Okuyama
Published 2020-01-01

Circulating Tumour DNA Reflects Tumour Burden Independently of Adverse Events Caused by Systemic Therapies for Melanoma

by Atsuko Ashida, Kaori Sakaizawa, Asuka Mikoshiba, Yukiko Kiniwa, Ryuhei Okuyama
Published 2019-09-01

Usefulness of monitoring circulating tumor cells as a therapeutic biomarker in melanoma with BRAF mutation

by Yukiko Kiniwa, Kenta Nakamura, Asuka Mikoshiba, Atsuko Ashida, Yasuyuki Akiyama, Atsushi Morimoto, Ryuhei Okuyama
Published 2021-03-01

Coexpression of EpCAM, CD44 variant isoforms and claudin-7 in anaplastic thyroid carcinoma.

by Toshihiro Okada, Teruo Nakamura, Takayuki Watanabe, Naoyoshi Onoda, Atsuko Ashida, Ryuhei Okuyama, Ken-ichi Ito
Published 2014-01-01

Multiple brain abscesses with good prognosis in an infant with cyanotic congenital heart disease: a case report

by Atsuko Kudo-Kubo, Shuichi Shimakawa, Yutaka Odanaka, Naokado Ikeda, Hikaru Kitahara, Hiromitsu Toshikawa, Atsuko Ashida, Miho Fukui, Noriyasu Ozaki, Kanta Kishi, Masahiko Wanibuchi, Akira Ashida
Published 2020-07-01